The spironolactone renaissance
@article{Doggrell2001TheSR, title={The spironolactone renaissance}, author={Sheila Anne Doggrell and Lindsay Brown}, journal={Expert Opinion on Investigational Drugs}, year={2001}, volume={10}, pages={943 - 954} }
Until recently, spironolactone was considered only as an antagonist at the aldosterone receptors of the epithelial cells of the kidney and was used clinically in the treatment of hyperaldosteronism and, occasionally, as a K+-sparing diuretic. The spironolactone renaissance started with the experimental finding that spironolactone reversed aldosterone-induced cardiac fibrosis by a cardiac action. Experimentally, spironolactone also has direct effects on blood vessels. Spironolactone reduces…
47 Citations
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs
- Medicine, BiologyExpert opinion on pharmacotherapy
- 2014
Both canrenone and hydrochlorothiazide can enhance the effect of treatment with ACE inhibitors and angiotensin II receptor blockers on microalbuminuria, but ALDO receptor blockers are more active.
Aldosterone, mineralocorticoid receptor, and heart failure
- Biology, MedicineMolecular and Cellular Endocrinology
- 2012
Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats.
- Biology, MedicineAmerican journal of physiology. Regulatory, integrative and comparative physiology
- 2003
Findings suggest that activation of MR in the central nervous system plays a critical role in regulating TNF-alpha release in heart failure rats, and some of the beneficial effect of blocking MR inHeart failure could be due at least in part to a reduction in TNF -alpha production.
Spironolactone in dermatology
- Medicine, BiologyDermatologic therapy
- 2022
The use of spironolactone in different skin diseases that are common in the authors' environment, dosage according to different studies, treatment recommendations and adverse effects; all of the above mentioned in order to use this drug in a daily clinical practice are discussed.
Spironolactone in Dermatology: A Mini Review
- Medicine, BiologyJournal of Pharmaceutical Research International
- 2021
The use of spironolactone in different skin diseases that are common in the authors' environment, dosage according to different studies, treatment recommendations and adverse effects; all of the above mentioned in order to use this drug in a daily clinical practice are discussed.
The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension
- Medicine, BiologyJournal of hypertension
- 2021
The antihypertensive action of spironolactone in resistant hypertensive patients is associated with suppressed IFN-γ and IL-6 and not IL-17A, which exerts anti-inflammatory actions in vivo on macrophages and T-cells.
Should the aldosterone-receptor antagonist – eplerenone – be used after acute myocardial infarction with left ventricular dysfunction?
- MedicineExpert opinion on pharmacotherapy
- 2003
Eplerenone should probably be added to the optimal therapy for use after acute MI with LV dysfunction, provided care is taken to avoid hyperkalaemia.
Determinants of spironolactone binding specificity in the mineralocorticoid receptor.
- Biology, ChemistryJournal of molecular endocrinology
- 2003
Analysis of this model in light of the experimental data suggested that spironolactone binding specificity is not governed by amino acids in the ligand-binding pocket.
Present and future pharmacotherapy for heart failure
- Medicine, BiologyExpert opinion on pharmacotherapy
- 2002
The pharmacotherapy currently recommended by the American College of Cardiology and the American Heart Association for heart failure is a diuretic, an angiotensin-converting enzyme inhibitor (ACEI), a β-adrenoceptor antagonist and (usually) digitalis, although digitalis does not reduce mortality.
Attenuation of adverse cardiac effects in prednisolone-treated δ-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism
- Biology, MedicineNeuromuscular Disorders
- 2010
References
SHOWING 1-10 OF 69 REFERENCES
Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure.
- Medicine, BiologyJournal of the American College of Cardiology
- 2000
Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure.
- MedicineThe American journal of cardiology
- 2000
Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
- Medicine, BiologyThe American journal of cardiology
- 1995
Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor.
- MedicineGeneral pharmacology
- 1998
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
- MedicineThe New England journal of medicine
- 1999
Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
- Medicine, BiologyHypertension research : official journal of the Japanese Society of Hypertension
- 1999
It is concluded that spironolactone may have beneficial effects on left ventricular hypertrophy in patients with essential hypertension who are receiving an angiotensin-converting enzyme inhibitor.
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.
- Medicine, BiologyCirculation
- 2000
Spironolactone improves endothelial dysfunction, increases NO bioactivity, and inhibits vascular Ang I/Ang II conversion in patients with heart failure, providing novel mechanisms for its beneficial effect on cardiovascular mortality.
Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.
- Medicine, BiologyThe American journal of cardiology
- 2000
Effect of spironolactone and its metabolites on contractile property of isolated rat aorta rings.
- BiologyJournal of cardiovascular pharmacology
- 2000
The effects of spironolactone, canrenone, and potassium canrenoate on contractile properties of isolated rat aorta rings are evaluated to suggest that these drugs could act through an inhibition of voltage-dependent Ca2+ channels.
Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
- Medicine, BiologyJournal of hepatology
- 1997